Item 5.07 Submission of Matters to a Vote of Security Holders
At the
a) Each of the Class I nominees of the Company's Board of Directors were elected to hold office until the Company's 2023 annual meeting of stockholders. The Class I nominees were:Jeffrey Bird , M.D., Ph.D.; 48,984,221 shares of Common Stock voted for, 1,241,675 withheld, and 13,340,539 broker non-votes;John H. Johnson ; 48,172,053 shares of Common Stock voted for, 2,053,843 withheld, and 13,340,539 broker non-votes; andH. Ward Wolff ; 48,697,269 shares of Common Stock voted for, 1,528,627 withheld, and 13,340,539 broker non-votes. The terms of office of Class II directorsDennis M. Fenton , Ph.D.,David C. Stump , M.D. andTed W. Love , M.D. continue until the Company's 2021 annual meeting of stockholders. The terms of office of Class III directorsLaura A. Brege ,Scott Garland andHollings C. Renton continue until the Company's 2022 annual meeting of stockholders. b) The stockholders approved, on a non-binding, advisory basis, of the compensation of the Company's named executive officers as disclosed in the Proxy Statement: 48,225,933 shares of Common Stock voted for, 1,900,229 against, 99,734 abstaining, and 13,340,539 broker non-votes. c) The stockholders ratified the selection by the Audit Committee of the Company's Board of Directors ofErnst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year endingDecember 31, 2020 : 62,613,691 shares of Common Stock voted for, 772,257 against, 180,487 abstaining, and 0 broker non-votes. 133289033 v2 --------------------------------------------------------------------------------
© Edgar Online, source